News

April 19 2021
mRNA, the magic potion to overcome MS?

mRNA, the magic potion to overcome MS?

Is a vaccine for MS a possibility in the futur? A pertinent question. Prof C. Sindic provides a hopeful answer.
March 22 2021
Multiple sclerosis and anti-Covid vaccination

Multiple sclerosis and anti-Covid vaccination

Are MS patients more affected by Covid-19? Are MS patients given priority in the vaccination plan?
January 25 2021
The laureates of the Charcot Fund 2021

The laureates of the Charcot Fund 2021

In 2020, Belgians donated over half a million euros to multiple-sclerosis research, which will be paid out in January 2021 by the Belgian Charcot Foundation to ten university teams.
4 janvier 2021
Best Wishes 2021

Best Wishes 2021

We are closing a very special year. Just like us, you are surely longing for a new beginning, a world where people can find each other again. Let us remain optimistic and united. We wish you all the best for 2021!
December 4 2020
The flu vaccine, MS and COVID-19

The flu vaccine, MS and COVID-19

The Belgian Charcot Foundation adheres to the guidelines of our health authorities, which are updated when necessary.
May 29 2020
Coronavirus and multiple sclerosis - update

Coronavirus and multiple sclerosis - update

The Belgian Charcot Foundation adheres to the guidelines of our health authorities, which are updated when necessary.
April 29 2020
Respect

Respect

Today's heroes are not only the care workers, but also the men and women in the shadows in logistics, the post office, garbage collectors, etc., not forgetting the researchers. Their mission is to find ways to solve this crisis, today but also tomorrow.
April 27 2020
Coronavirus and multiple sclerosis

Coronavirus and multiple sclerosis

The Charcot Foundation refers to the general information on the website of the Belgian health authorities. The Charcot Foundation agrees with the opinion of the Belgian Multiple Sclerosis Study Group concerning the current coronavirus problem, namely:
January 24 2020
Innovation Made in Belgium

Innovation Made in Belgium

With 500,000 euros, the Fondation Charcot Stichting provides the essential resources for 10 teams of experienced researchers in neurology, neuroimmunology, neurobiology and rehabilitation sciences to ensure innovative and concrete advances in multiple sclerosis research.
January 2, 2020
Anne Vandamme, suffering from multiple sclerosis: I am living in the moment, with the abilities that I still have!

Anne Vandamme, suffering from multiple sclerosis: I am living in the moment, with the abilities that I still have!

Multiple sclerosis (MS) affects 12,000 people in our country. Anne Vandamme is one of them. An inspiring conversation with a patient for whom the glass is always half full, never half empty.
December 23 2019
Cannabis and MS

Cannabis and MS

Multiple sclerosis is a chronic inflammatory disease of the central nervous system that affects over two million people worldwide. Patients may suffer from a wide range of disabling complaints which are not always easy to treat. Although cannabis is best known as a psychoactive recreational drug, it is also increasingly associated with a variety of positive medical effects.
November 4 2019
Young adults and MS

Young adults and MS

Multiple sclerosis is the commonest neurological disease affecting young adults. In patients under 30, treatment needs to be adjusted accordingly.

Stay informed

Receive all the information related to research and news from the Belgian Charcot Foundation directly in your inbox.

By clicking on “I register”, you agree to our Privacy policy